1. Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzumab for treatment-naive chronic lymphocytic leukaemia (ELEVATE-TN): a randomised, controlled, phase 3 trial. Issue 10232 (18th April 2020) Authors: Sharman, Jeff P; Egyed, Miklos; Jurczak, Wojciech; Skarbnik, Alan; Pagel, John M; Flinn, Ian W; Kamdar, Manali; Munir, Talha; Walewska, Renata; Corbett, Gillian; Fogliatto, Laura Maria; Herishanu, Yair; Banerji, Versha; Coutre, Steven; Follows, George; Walker, Patricia; Karlsson, Karin; Ghia, Pao... Journal: Lancet Issue: Volume 395:Issue 10232(2020) Page Start: 1278 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Brentuximab vedotin plus nivolumab after autologous haematopoietic stem-cell transplantation for adult patients with high-risk classic Hodgkin lymphoma: a multicentre, phase 2 trial. Issue 1 (January 2023) Authors: Herrera, Alex F; Chen, Lu; Nieto, Yago; Holmberg, Leona; Johnston, Patrick; Mei, Matthew; Popplewell, Leslie; Armenian, Saro; Cao, Thai; Farol, Leonardo; Sahebi, Firoozeh; Spielberger, Ricardo; Chen, Robert; Nademanee, Auayporn; Puverel, Sandrine; Nwangwu, Mary; Lee, Peter; Song, Joo; Skarbnik, A... Journal: Lancet Issue: Volume 10:Issue 1(2023) Page Start: e14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Comparable outcomes in chronic lymphocytic leukaemia (CLL) patients treated with reduced‐dose ibrutinib: results from a multi‐centre study. (21st February 2017) Authors: Mato, Anthony R.; Timlin, Colleen; Ujjani, Chaitra; Skarbnik, Alan; Howlett, Christina; Banerjee, Rahul; Nabhan, Chadi; Schuster, Stephen J. Journal: British journal of haematology Issue: Volume 181:Number 2(2018) Page Start: 259 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗